NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $12.41 -0.02 (-0.16%) As of 03:22 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$12.11▼$12.4450-Day Range$9.87▼$13.7052-Week Range$9.79▼$20.36Volume216,450 shsAverage Volume590,656 shsMarket Capitalization$569.37 millionP/E Ratio22.16Dividend Yield0.32%Price TargetN/AConsensus RatingHold Company Overview Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation. Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 47% of companies evaluated by MarketBeat, and ranked 157th out of 250 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth49.06% Earnings GrowthEarnings for Core Laboratories are expected to grow by 49.06% in the coming year, from $0.53 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 21.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.69.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 21.98, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 19.96.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 2.95. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.26% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 5.02.Change versus previous monthShort interest in Core Laboratories has recently increased by 4.24%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.33%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social Media3.1 / 5News SentimentN/A News SentimentCore Laboratories has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 1 news article for Core Laboratories this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. Company Ownership2.9 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0095% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesThe Top 5 Analyst Questions From Core Laboratories’s Q2 Earnings CallAugust 5, 2026 | msn.comCore Laboratories (NYSE:CLB) CEO Lawrence Bruno Purchases 5,000 Shares of StockAugust 5, 2026 | insidertrades.comBlackRock owns 32 million shares of THISInstitutions already control 88% of this company's shares. BlackRock holds roughly 32 million shares, Vanguard about 48 million, and management just authorized a 40-million-share buyback. This energy business generates billions in operating income and is now using Palantir's AI technology to boost operations, yet it still trades at a valuation under 8 billion dollars.August 12 at 1:00 AM | Monument Traders Alliance (Ad)CLB Q2 Deep Dive: Geopolitical Headwinds and Technology Adoption Shape ResultsAugust 4, 2026 | finance.yahoo.comCore Laboratories (NYSE:CLB) Upgraded at Wall Street ZenAugust 1, 2026 | americanbankingnews.comCore Laboratories (CLB) Q2 2026 EarningsJuly 31, 2026 | 247wallst.comCore Laboratories Earnings Call Signals Gradual RecoveryJuly 30, 2026 | tipranks.comCore Laboratories (NYSE:CLB) misses Q2 CY2026 sales expectationsJuly 30, 2026 | msn.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the start of the year. Since then, CLB shares have decreased by 23.2% and is now trading at $12.31. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) released its quarterly earnings data on Wednesday, July, 29th. The oil and gas company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. The business's revenue for the quarter was down 4.3% compared to the same quarter last year. Read the conference call transcript. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional investors include BlackRock Inc. (16.26%), Heartland Advisors Inc. (2.31%), Bank of New York Mellon Corp (0.87%) and Advisors Capital Management LLC (0.52%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Record date for 6/1 Dividend5/11/2026Ex-Dividend for 6/1 Dividend5/11/2026Dividend Payable6/01/2026Last Earnings7/29/2026Record date for 8/31 Dividend8/10/2026Ex-Dividend for 8/31 Dividend8/10/2026Today8/12/2026Dividend Payable8/31/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 CLB's financial health is in the Red zone, according to TradeSmith. CLB has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry Energy Equipment & Services Sub-IndustryOil & Gas Equipment & Services Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Profitability EPS (Trailing Twelve Months)$0.56 Trailing P/E Ratio21.98 Forward P/E Ratio23.23 P/E Growth2.95Net Income$29.67 million Net Margins5.10% Pretax Margin7.09% Return on Equity10.03% Return on Assets4.71% Debt Debt-to-Equity Ratio0.41 Current Ratio2.12 Quick Ratio1.55 Sales & Book Value Annual Sales$526.52 million Price / Sales1.07 Cash Flow$1.08 per share Price / Cash Flow11.44 Book Value$6.08 per share Price / Book2.02Miscellaneous Outstanding Shares45,880,000Free Float45,307,000Market Cap$564.78 million OptionableOptionable Beta1.03 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSE:CLB) was last updated on 8/12/2026 by MarketBeat.com Staff. From Our PartnersBlackRock owns 32 million shares of THISInstitutions already control 88% of this company's shares. BlackRock holds roughly 32 million shares, Vanguard...Monument Traders Alliance | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThe trading strategy that works BECAUSE you have a lifeTim Sykes built a trading strategy for people who can't watch charts from 9:30 to 4:00 every day. It's not ...Tim Sykes | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.